Storia in 9 fonti

New daily weight loss pill helps people shed 10 per cent of body weight

The pill doesn’t have the fasting requirements of many other weight loss drugs

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

independent.co.ukStai leggendo1 mese fa

New daily weight loss pill helps people shed 10 per cent of body weight

The pill doesn’t have the fasting requirements of many other weight loss drugs

originale

Timeline cronologica

lunedì 8 giugno 2026·morningstar.com
Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results
Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results
lunedì 8 giugno 2026·endpoints.news
AstraZeneca's obesity pill matches rivals in Phase 2, anchoring $5B franchise push
AstraZeneca's oral GLP-1 elecoglipron cut weight up to 10.5% in Phase 2, as AZ launches multiple Phase 3 trials targeting a $5B obesity franchise.

france24.com

1 mese fa

Encouraging trial results for AstraZeneca's new weight-loss pill

A new pill developed by the British pharma firm AstraZeneca appears to help people lose a similar amount of weight to other GLP-1 oral drugs, trial results showed Monday.

Leggi questa versione → originale

dailymail.com1 mese fa

New daily pill helps obese patients lose a tenth of bodyweight

An experimental daily weight loss pill helped people shift more than ten per cent of their bodyweight after six months, research has found.

Leggi questa versione → originale

medpagetoday.com1 mese fa

Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

Investigational pill was well-tolerated and doesn't come with food or water restrictions

Leggi questa versione → originale

morningstar.com1 mese fa

Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results

Leggi questa versione → originale

benzinga.com1 mese fa

AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials - AstraZeneca (NYSE:AZN)

AstraZeneca advances oral GLP-1 elecoglipron to Phase 3 following strong weight loss & diabetes data at ADA 2026. Get the trial details.

Leggi questa versione → originale

lunedì 8 giugno 2026·

dailymail.com

New daily pill helps obese patients lose a tenth of bodyweight

An experimental daily weight loss pill helped people shift more than ten per cent of their bodyweight after six months, research has found.

lunedì 8 giugno 2026·

eluniversal.com.mx

AstraZeneca se suma al mercado contra la obesidad, nueva pastilla da resultados alentadores en ensayo clínico

Especialistas consideran que el medicamento merece evaluaciones más amplias antes de solicitar su autorización

martedì 9 giugno 2026·

publico.pt

Comprimido da AstraZeneca para a obesidade ajuda doentes a perder 10,5% do peso

Doentes perderam 10,5% do peso em 26 semanas num ensaio intermédio da pílula experimental da AstraZeneca, que quer disputar o mercado do emagrecimento com a Novo Nordisk e a Eli…

martedì 9 giugno 2026·

france24.com

Encouraging trial results for AstraZeneca's new weight-loss pill

A new pill developed by the British pharma firm AstraZeneca appears to help people lose a similar amount of weight to other GLP-1 oral drugs, trial results showed Monday.

martedì 9 giugno 2026·

medpagetoday.com

Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

Investigational pill was well-tolerated and doesn't come with food or water restrictions

martedì 9 giugno 2026·

benzinga.com

AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials - AstraZeneca (NYSE:AZN)

AstraZeneca advances oral GLP-1 elecoglipron to Phase 3 following strong weight loss & diabetes data at ADA 2026. Get the trial details.

mercoledì 10 giugno 2026·

independent.co.uk

New daily weight loss pill helps people shed 10 per cent of body weight

The pill doesn’t have the fasting requirements of many other weight loss drugs

mercoledì 10 giugno 2026·

independent.co.uk

AstraZeneca daily pill shows promising weight loss results in trial

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

New daily weight loss pill helps people shed 10 per cent of body weight

Timeline cronologica

Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results

AstraZeneca's obesity pill matches rivals in Phase 2, anchoring $5B franchise push

Encouraging trial results for AstraZeneca's new weight-loss pill

New daily pill helps obese patients lose a tenth of bodyweight

Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results

AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials - AstraZeneca (NYSE:AZN)

New daily pill helps obese patients lose a tenth of bodyweight

AstraZeneca se suma al mercado contra la obesidad, nueva pastilla da resultados alentadores en ensayo clínico

Comprimido da AstraZeneca para a obesidade ajuda doentes a perder 10,5% do peso

Encouraging trial results for AstraZeneca's new weight-loss pill

Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials - AstraZeneca (NYSE:AZN)

New daily weight loss pill helps people shed 10 per cent of body weight

AstraZeneca daily pill shows promising weight loss results in trial